Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Remission and relapses of myasthenia gravis on long-term tacrolimus: a retrospective cross-sectional study of a Chinese cohort. | Ther Adv Chronic Dis | 2022 | 36093262 | PubTator, text mining | PubMed |
| SAPHO Syndrome Presenting With Atlo-Epistrophic Synovitis and Left Vocal Cord Paresis: A Challenging Diagnosis. | Clin Med Insights Arthritis Musculoskelet Disord | 2022 | 36090594 | PubTator, text mining | PubMed |
| The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors. | Cancers (Basel) | 2022 | 36077762 | PubTator, text mining | PubMed |
| Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities. | Acta Neuropathol | 2022 | 36074148 | PubTator, text mining | PubMed |
| Establishment of embryo transfer in the musk shrew (Suncus murinus). | J Reprod Dev | 2022 | 36070889 | PubTator, text mining | PubMed |
| Checkpoint Immunotherapy-Induced Myocarditis and Encephalitis Complicated With Complete AV Block: Not All Hope Is Lost. | JACC Case Rep | 2022 | 36062054 | PubTator, text mining | PubMed |
| A single low-dose rituximab infusion in severe chronic refractory myasthenia gravis in resource-limited settings. | J Neurol Sci | 2022 | 36057244 | PubTator, text mining | PubMed |
| Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study. | Front Pharmacol | 2022 | 36052140 | PubTator, text mining | PubMed |
| Myasthenia Gravis Presenting after Administration of the mRNA-1273 Vaccine. | Eur J Case Rep Intern Med | 2022 | 36051160 | PubTator, text mining | PubMed |
| New-Onset Ocular Myasthenia Gravis After Booster Dose of COVID-19 Vaccine. | Cureus | 2022 | 36035038 | PubTator, text mining | PubMed |
| Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing. | Front Oncol | 2022 | 36033527 | PubTator, text mining | PubMed |
| Low-Density Lipoprotein Receptor-Related Protein 8 at the Crossroad between Cancer and Neurodegeneration. | Int J Mol Sci | 2022 | 36012187 | PubTator, text mining | PubMed |
| LeMeDISCO is a computational method for large-scale prediction & molecular interpretation of disease comorbidity. | Commun Biol | 2022 | 36008469 | PubTator, text mining | PubMed |
| Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy. | Cureus | 2022 | 36004023 | PubTator, text mining | PubMed |
| Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis. | Brain Commun | 2022 | 35999839 | PubTator, text mining | PubMed |
| Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study. | J Neurol | 2022 | 35995991 | PubTator, text mining | PubMed |
| Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study. | Front Immunol | 2022 | 35990671 | PubTator, text mining | PubMed |
| Factors affecting the intention of COVID-19 vaccination in Korean patients with myasthenia gravis: A survey-based study. | Front Neurol | 2022 | 35989937 | PubTator, text mining | PubMed |
| Gene-diet interactions and cardiovascular diseases: a systematic review of observational and clinical trials. | BMC Cardiovasc Disord | 2022 | 35987633 | PubTator, text mining | PubMed |
| Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study. | Front Immunol | 2022 | 35979348 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=39